MicroPort NeuroTech Artemis Dream intracranial rapamycin stent enters NMPA innovative device green channelPUBT·Jul 29 at 07:09 PM02172+0.22%
MicroPort NeuroScientific announces final dividend of HK$ 0.09 per share, offers scrip optionPUBT·Jul 22 at 04:36 AM02172+0.22%
MicroPort NeuroScientific files HKEX next-day return disclosing share repurchase at HKD 10.98 eachPUBT·Jun 29 at 07:38 AM02172+0.22%
MicroPort NeuroScientific files HKEX next-day return disclosing share buyback at HKD 10.61-10.82PUBT·Jun 26 at 06:13 AM02172+0.22%
STOCKS | Hong Kong Brain-Computer Interface Shares Fall, Lenovo Down More Than 6%CoinLive·Jun 26 at 04:41 AM066810.00%LNVGY+7.03%
MicroPort NeuroScientific files HKEX next-day disclosure return, reports share repurchasePUBT·Jun 24 at 06:36 AM02172+0.22%
MicroPort NeuroScientific files HKEX next-day disclosure return on share buyback cancellationPUBT·Jun 22 at 08:21 AM02172+0.22%
MicroPort NeuroScientific Expands Share Buy-Back, Citing Undervalued StockTip Ranks·Jun 2 at 10:13 AM02172+0.22%
Bank of America Securities lowers the target price for MicroPort to 13.9 yuan, reiterating a "Buy" ratingAASTOCKS·Apr 8 at 01:59 AM021600.00%688351-5.00%
CICC Reaffirms Their Buy Rating on MicroPort NeuroTech Limited (2172)Tip Ranks·Apr 4 at 12:25 AM02172+0.22%159898+1.45%
"Performance" MICROPORT achieved a net profit of USD 48.52 million for the entire year, turning a loss into a profitAASTOCKS·Mar 31 at 12:51 PM021600.00%02252+4.10%
